The Valley Desk

ReviewMuscle & nervePublished

Single institution experience with efgartigimod in patients with myasthenia gravis: Patient selection, dosing schedules, treatment response, and adverse events

Read the publication ↗

Regional connection

Verified An author affiliation on the Europe PMC record names University of Pennsylvania. Affiliation source

Publication record

Type
Review
Venue
Muscle & nerve
Published
Subject terms
Humans; Myasthenia Gravis; Autoantibodies; Activities of Daily Living; Behavior Therapy; Patient Selection; Infant, Newborn; Myasthenia gravis; Mg-adl; Efgartigimod; Achr Positive; Fcrn Inhibitor
PubMed ID
37990374
Added to directory
Source checked

Report a correction or request removal